C07K 14/4726
Lectins
Official title: {Lectins}
C07K14/4726 (Lectins) appears on 156 US grants and 261 published applications in this corpus.
Search patents in C07K- Granted patents
- 156
- Published applications
- 261
- Assignees
- 176
- Inventors
- 591
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 1 |
| 2002 | 5 | 5 |
| 2003 | 4 | 18 |
| 2004 | 2 | 11 |
| 2005 | 4 | 6 |
| 2006 | 5 | 6 |
| 2007 | 4 | 10 |
| 2008 | 4 | 9 |
| 2009 | 1 | 8 |
| 2010 | 3 | 16 |
| 2011 | 5 | 11 |
| 2012 | 4 | 13 |
| 2013 | 7 | 10 |
| 2014 | 6 | 10 |
| 2015 | 5 | 12 |
| 2016 | 6 | 11 |
| 2017 | 7 | 9 |
| 2018 | 7 | 13 |
| 2019 | 9 | 10 |
| 2020 | 7 | 14 |
| 2021 | 10 | 12 |
| 2022 | 8 | 10 |
| 2023 | 7 | 12 |
| 2024 | 7 | 8 |
| 2025 | 3 | 11 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-Galectin-9 antibodies and uses thereof25 Aug 2026US 12,715,922 B2New York University
- CLEC2 fusion protein and uses thereof5 May 2026US 12,617,826 B2Academia Sinica
- Self-diversifying systems and methods of use thereof21 Apr 2026US 12,606,815 B2Massachusetts Institute of Technology
- Galectin-1/ galectin-3 chimeras and multivalent proteins17 Mar 2026US 12,577,282 B2University of Florida Research Foundation, Inc.
- Pharmaceutical composition, comprising recombinant stabilized galectin 9 protein, for prevention or treatment of rheumatoid arthritis and bone disease21 Oct 2025US 12,448,420 B2Gbiologics Inc.
- T-Cell Modulatory Polypeptides and Methods of Use Thereof2 Jul 2026US 2026/0184762 A1Cue Biopharma, Inc.
- Variant anti-viral polypeptides2 Apr 2026US 2026/0092088 A1International N&H Denmark Aps
- Anti-galectin-9 antibodies and uses thereof12 Feb 2026US 2026/0042846 A1New York University
- Pharmaceutical composition, comprising recombinant stabilized galectin 9 protein, for prevention or treatment of rheumatoid arthritis and bone disease15 Jan 2026US 2026/0015394 A1Gbiologics Inc.
- Fusion protein comprising a surfactant-protein-d and a member of the tnfsf15 Jan 2026US 2026/0015405 A1Transgene S. A.
Most cited
By later US patents
- Galectin-11 polypeptides65US 6,605,699 B1Human Genome Sciences, Inc. · 2003
- Human mannose-binding protein51US 5,270,199 AChildren's Medical Center Corporation · 1993
- Engineered opsonin for pathogen detection and treatment39US 9,150,631 B2President and Fellows of Harvard College · 2015
- Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals35US 6,562,784 B12003
- Recombinant human mannan-binding lectin32US 6,846,649 B12005